Relay Therapeutics (RLAY)

• Market cap: $4.1B
• 1 day: -3.19%
• 5 days: 1.95%
• 1 month: 0.64%
• 3 months: 45.29%
• 6 months: 131.04%
• Year to date: 130.2%
• 1 year: 434.94%
• 5 years: -42.97%
• 10 years: -46.28%
• Sector: Healthcare
• Industry: Biotechnology

About: Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Employees: 192